MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202617071653 A) filed by Shenzhen Targetrx Co. , Ltd. on June 09, 2026, for Method For Treating Alk-Positive Or Ros1-Positive Non-Small Cell Lung Cancer.
Inventors include Wang, Yihan; Cao, Jingrong Number; Liu, Yun; and Li, Huanyin.
The application for the patent was published on July 10, 2026, under issue no. 28/2026.
Abstract: Provided is a method for treating ALK-positive non-small cell lung cancer in a subject by means of administering a compound A or a pharmaceutically acceptable salt thereof to the subject. Further provided is a method for treating ROS1-positive non-small cell lung cancer in a subject by means of administering compound A or a pharmaceutically acceptable salt thereof to the subject.
Disclaimer: Curated by HT Syndication.
